By Kelly A. Briganti, Editorial Director, G2 Intelligence
As the year came to a close, the Federal Bureau of Investigation and the U.S. Attorney's Office announced December 30, 2015, a $4 million settlement with Pathway Genomics. The San Diego-based laboratory denied wrongdoing but agreed to pay that sum to resolve…
Read more...
By Ron Shinkman, Editor, Laboratory Industry Report
Florida-based NeoGenomics has completed its acquisition of the Clarient Diagnostics unit from GE Healthcare. Clarient provides cancer diagnostics to hospitals, physicians, and drug companies…
Read more...
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
Simple, brief, information sheets are unlikely to change patients' intentions to participate in low-value screenings, according to a study published online Dec. 28, 2015 in JAMA Internal Medicine. To reduce overused screening services—including prostate cancer and…
Read more...
By Kelly A. Briganti, Editorial Director, G2 Intelligence
Laboratory safety and diagnosis of infections figure prominently in the Centers for Disease Control and Prevention's (CDC) review of 2015 and its agenda for 2016. The agency's Year in Review highlighted "the most pressing public health challenges of…
Read more...
|
